Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hamburg/Sharfstein Agenda For FDA Emphasizes Collaboration

Executive Summary

Collaboration will be a key tool used by FDA Commissioner Margaret Hamburg as she leads the agency beyond its role as regulator to be a vigilant protector of public health

You may also be interested in...



Pediatric Safety For Anesthetic Drugs Boosted In FDA/IARS Initiative

FDA and the International Anesthetic Research Society have solidified their partnership for collaborating on the safe use of anesthetics and sedatives in children with a memorandum of understanding that focuses as much on communication as on research

Pediatric Safety For Anesthetic Drugs Boosted In FDA/IARS Initiative

FDA and the International Anesthetic Research Society have solidified their partnership for collaborating on the safe use of anesthetics and sedatives in children with a memorandum of understanding that focuses as much on communication as on research

FDA Appropriations In Senate: Money For Generics; Worry About Tobacco

Senate appropriators would like to see FDA spend $93 million in fiscal year 2010 on its generic drugs program

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel